首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)]center dot-EtOH
【24h】

Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)]center dot-EtOH

机译:具有铜(II)的消炎药替诺昔康(Htenox)的形态研究:[Cu(tenox)(2)(py)(2)]中心点-EtOH的X射线晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

A speciation study was carried out in aqueous solution of the anti-inflammatory drug tenoxicam (Htenox), under quasi-physiological conditions (temperature of 37 degreesC and ionic strength 0.15 M NaCl) in order to determine the acidity constants from spectrophotometric studies, the pK(a) values found being pK(1) = 1.143 +/- 0.008 and pK(2) = 4.970 +/- 0.004. Subsequently, the spectrophotometrical speciation of the different complexes of Cu(II) with the drug was performed under the same conditions of temperature and ionic strength, observing the formation of Cu(Htenox)(2)(2+) with log beta(212) = 20.05 +/- 0.01, Cu(Htenox)(2) with log beta(012) = 13.6 +/- 0.1, Cu(Htenox)(2+) with log beta(111) = 10.52 +/- 0.08, as well as Cu(tenox)(+) with log beta(011) = 7.0 +/- 0.2, all of them in solution, and solid species Cu(tenox)(2)(s) with an estimated value of log beta(012)(s)approximate to18.7. The crystalline structure of the complex [Cu(tenox)(2)(py)(2)](EtOH)-Et-., was also determined, and it was observed that tenoxicam employs the oxygen of the amide group and the pyridyl nitrogen to bond to the cation. (C) 2003 Elsevier Science Inc. All rights reserved. [References: 64]
机译:为了在分光光度法研究中确定酸度常数,在准生理条件(温度为37摄氏度,离子强度为0.15 M NaCl)下,在抗炎药替诺昔康(Htenox)的水溶液中进行了形态研究。 (a)值分别为pK(1)= 1.143 +/- 0.008和pK(2)= 4.970 +/- 0.004。随后,在相同的温度和离子强度条件下,对Cu(II)与药物的不同配合物进行分光光度形成,观察到形成了log beta(212)的Cu(Htenox)(2)(2+)。 = 20.05 +/- 0.01,Cu(Htenox)(2)的log beta(012)= 13.6 +/- 0.1,Cu(Htenox)(2+)的log beta(111)= 10.52 +/- 0.08形式为对数beta(011)= 7.0 +/- 0.2的Cu(tenox)(+),它们都在溶液中,以及估计对数beta(012)的固态Cu(tenox)(2)(s) (s)约等于18.7。还确定了复合物[Cu(tenox)(2)(py)(2)](EtOH)-Et-。的晶体结构,并观察到替诺昔康使用酰胺基的氧和吡啶基氮结合到阳离子上。 (C)2003 Elsevier Science Inc.保留所有权利。 [参考:64]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号